Ablative therapies for intrahepatic cholangiocarcinoma 被引量：2

导出

摘要 Among the 3 sub-types of cholangiocarcinoma (CH), [intrahepatic CH, hylar (CH) and extrahepatic (CH)], intrahepatic cholangiocarcinoma (ICC) accounts for up 8–10% of cholangiocarcinomas and 10–20% of all primary liver tumors (1).

作者 Antonio Giorgio Pietro Gatti Paolo Matteucci Valentina Giorgio

机构地区 Interventional Ultrasound Unit Internal Medicine Division Radiation Oncology Institute Pediatric Gastroenterology Unit

出处《Hepatobiliary Surgery and Nutrition》 SCIE 2018年第3期192-194,共3页 肝胆外科与营养（英文）

关键词 CARCINOMA LIVER for

分类号 R73 [医药卫生—肿瘤]

引文网络
相关文献

同被引文献12

1Dong-Yu Li,Hai-Bin Zhang,Ning Yang,Yuan Quan,Guang-Shun Yang.Routine lymph node dissection may be not suitable for all intrahepatic cholangiocarcinoma patients: Results of a monocentric series[J].World Journal of Gastroenterology,2013,19(47):9084-9091. 被引量：31
2Ozlem Yonem,Yusuf Bayraktar.Clinical characteristics of Caroli’s disease[J].World Journal of Gastroenterology,2007,13(13):1930-1933. 被引量：20
3董辉,丛文玲,朱忠政,王斌,冼志红,俞花.肝细胞癌与肝内胆管癌的免疫组化诊断[J].中华肿瘤杂志,2008,30(9):702-705. 被引量：12
4李增山,李青.2010年版消化系统肿瘤WHO分类解读[J].中华病理学杂志,2011,40(5):351-354. 被引量：71
5丛文铭,步宏,陈杰,董辉,朱玉瑶,冯龙海,陈骏.原发性肝癌规范化病理诊断指南(2015年版)[J].解放军医学杂志,2015,40(11):865-872. 被引量：225
6万福臻,朱韬,刘付宝.比较开放与腔镜肝切除术治疗肝内胆管细胞癌围手术期及肿瘤相关预后[J].肝胆外科杂志,2016,24(4):320-320. 被引量：27
7陆巍,汤朝晖,全志伟.肝内胆管癌淋巴结清扫相关问题的探讨[J].中华外科杂志,2019,57(4):247-252. 被引量：18
8李昊昱,李俊,沈锋.肝内胆管癌常见分型方法及诊治回顾[J].临床与病理杂志,2019,39(5):1123-1128. 被引量：4
9科技部传染病防治重大专项课题“病毒性肝炎相关肝癌外科综合治疗的个体化和新策略研究”专家组,陈孝平,沈锋,王葵,夏勇,程张军.肝内胆管癌外科治疗中国专家共识(2020版)[J].中华消化外科杂志,2021,20(1):1-15. 被引量：78
10杨扬,周家华.肝内胆管细胞癌微创治疗现状及进展[J].中国肿瘤外科杂志,2021,13(1):1-4. 被引量：9

引证文献2

1科技部传染病防治重大专项课题“病毒性肝炎相关肝癌外科综合治疗的个体化和新策略研究”专家组,陈孝平,沈锋,王葵,夏勇,程张军.肝内胆管癌外科治疗中国专家共识(2020版)[J].中华消化外科杂志,2021,20(1):1-15. 被引量：78
2宋双龙,王石.肝内胆管癌治疗研究进展[J].内蒙古医学杂志,2021,53(8):942-944.

二级引证文献78

1张晓帅,付航玮,卢绮萍.纳米材料在肿瘤影像学诊断中的应用[J].肿瘤,2023,43(6):478-489. 被引量：1
2段诣,胡粟衔,杨旭鹏,武志华,段友容,孙颖.肝内胆管癌的分子靶向治疗研究进展[J].肿瘤,2022,42(11):750-760. 被引量：4
3张辉,陈志宇,弓毅,戴海粟,谭斌彬,牟玮,张雷达.经肝动脉化疗栓塞联合免疫靶向治疗晚期不可切除肝内胆管细胞癌的临床疗效[J].中华消化外科杂志,2021,20(S02):37-40. 被引量：5
4王冲,程石.肝内胆管癌——国内外专家共识及指南解读[J].外科理论与实践,2021,26(2):124-129. 被引量：9
5刘红枝,林自国,黄建龙,周伟平,程张军,楼健颖,郑树国,毕新宇,王剑明,郭伟,李富宇,王坚,郑亚民,李敬东,程石,刘景丰,曾永毅.切缘宽度对单发肝内胆管癌预后影响的多中心研究[J].外科理论与实践,2021,26(2):130-137. 被引量：4
6宋双龙,王石.肝内胆管癌治疗研究进展[J].内蒙古医学杂志,2021,53(8):942-944.
7卢绮萍.注重胆道外科临床研究提高论文报告证据质量[J].中华消化外科杂志,2021,20(8):850-857. 被引量：2
8高龙,吴越,闫海丽,丰继平,杜江锋,冯对平.肝内胆管癌的局部治疗现状与研究进展[J].中华放射学杂志,2021,55(10):1103-1107. 被引量：3
9刘处处,吴美龙,严哲,杨江辉,冯晓彬.术前中性粒细胞与淋巴细胞比值在肝内胆管细胞癌肝部分切除术后的预后价值的meta分析[J].实用肿瘤杂志,2021,36(6):514-519. 被引量：6
10张志浩,刘锋.肝内胆管细胞癌外科治疗进展[J].中国临床新医学,2022,15(2):100-104. 被引量：4

1Yasunori Minami,Masatoshi Kudo.Adjuvant therapy after radical surgery for hepatocellular carcinoma: still an unmet need[J].Hepatobiliary Surgery and Nutrition,2019,8(4):414-416.
2Ernesto Sparrelid,Thomas M.van Gulik.Tumor progression in two-stage liver resections—is the shorter inter-stage period in associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) of benefit to the patient?[J].Hepatobiliary Surgery and Nutrition,2019,8(3):316-317. 被引量：4
3Eyal Mor,Abbas Al-Kurd,Almog Ben Yaacov,Dan Aderka,Aviram Nissan,Arie Ariche.Surgical outcomes of two-stage hepatectomy for colorectal liver metastasis: comparison to a benchmark procedure[J].Hepatobiliary Surgery and Nutrition,2019,8(1):29-36. 被引量：3
4Takumi Onoyama,Yohei Takeda,Taro Yamashita,Wataru Hamamoto,Yuri Sakamoto,Hiroki Koda,Soichiro Kawata,Kazuya Matsumoto,Hajime Isomoto.Programmed cell death-1 inhibitor-related sclerosing cholangitis:A systematic review[J].World Journal of Gastroenterology,2020,26(3):353-365. 被引量：14
5Adriano Carneiro da Costa,Mikael Sodergren,Kumar Jayant,Fernando Santa Cruz,Duncan Spalding,Madhava Pai,Nagy Habib.Radiofrequency combined with immunomodulation for hepatocellular carcinoma: State of the art and innovations[J].World Journal of Gastroenterology,2020,26(17):2040-2048. 被引量：6
6何自倩,王渠,曾利川.ROC评价MRI、超声对肝内外胆管结石的诊断效能[J].中国CT和MRI杂志,2020,18(6):93-95. 被引量：8
7Chen Li,Hai-Bin Su,Xiao-Yan Liu,Jin-Hua Hu.Clinical characteristics and 28-d outcomes of bacterial infections in patients with hepatitis B virus-related acute-on-chronic liver failure[J].World Journal of Clinical Cases,2020,8(6):1042-1055. 被引量：16
8Jung Wan Choe,Hyo Jung Kim,Jae Seon Kim.Survival improvement and prognostic factors in recent management of extrahepatic cholangiocarcinoma:A single-center study[J].Hepatobiliary & Pancreatic Diseases International,2020,19(2):153-156. 被引量：2
9Miao Wang,Jiamin Zhou,Lyu Zhang,Yiming Zhao,Ning Zhang,Longrong Wang,Weiping Zhu,Xigan He,Hongxu Zhu,Weiqi Xu,Qi Pan,Anrong Mao,Qinchuan Li,Lu Wang.Surgical treatment of ovarian cancer liver metastasis[J].Hepatobiliary Surgery and Nutrition,2019,8(2):129-137. 被引量：5
10Zhe-Xuan Wang,Jing Li,En-Xin Wang,Dong-Dong Xia,Wei Bai,Qiu-He Wang,Jie Yuan,Xiao-Mei Li,Jing Niu,Zhan-Xin Yin,Jie-Lai Xia,Dai-Ming Fan,Guo-Hong Han.Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolization[J].World Journal of Gastroenterology,2020,26(15):1805-1819. 被引量：2

Hepatobiliary Surgery and Nutrition

2018年第3期

浏览历史

内容加载中请稍等...

Ablative therapies for intrahepatic cholangiocarcinoma 被引量：2

同被引文献12

引证文献2

二级引证文献78

相关作者

相关机构

相关主题

浏览历史